AesMed successfully participated as an exhibitor in two major medical and academic events held in Seoul in May 2026: the KALDAT 2026 Conference and the 18th Annual Meeting of the Korean Society of Hair Restoration Surgery (KSHRS) 2026.
Through these consecutive exhibitions, AesMed had the opportunity to connect with dermatologists, hair restoration surgeons, clinicians, and industry professionals, while presenting its science-driven approach to hair-loss treatment and regenerative scalp care.
Engaging with Dermatology and Trichology Experts at KALDAT 2026
On May 3, 2026, AesMed exhibited at the KALDAT 2026 Conference, held at COEX Hall C in Seoul. KALDAT is one of Korea’s leading academic events in laser medicine, dermatology, and trichology, bringing together medical professionals and industry leaders to explore the latest developments in aesthetic and clinical practice.
At Booth C37, AesMed introduced its core solutions for professional hair-loss treatment and scalp care, including:
CytoMesopecia – Cytokines Mesotherapy for Alopecia
AesMed’s proprietary clinical framework designed to standardize cytokine-based therapy for effective, reproducible, and clinically applicable hair regrowth treatment.
AGF39
A cytokine-based professional solution used within CytoMesopecia protocols, developed to support clinical hair-loss treatment and widely introduced to medical professionals in Korea and global markets.
4th Generation Advance Follicle Shampoo
A scalp-care formulation featuring a Nonionic Surfactant-based system, designed to offer a mild, biocompatible, and clinic-friendly approach to daily scalp care.
The KALDAT exhibition provided AesMed with a valuable platform to share its treatment concepts, communicate with dermatology specialists, and highlight the importance of integrated scalp-care solutions that connect clinical treatment with ongoing hair wellness.
Continuing the Conversation at KSHRS 2026
One week later, AesMed continued its academic engagement at the 18th Annual Meeting of the Korean Society of Hair Restoration Surgery (KSHRS) 2026, held at the Grand InterContinental Seoul Parnas. The KSHRS 2026 congress program was organized across May 9–10, 2026, with the May 10 sessions focusing on a broad range of topics in medical hair-loss treatment, clinical insights, and hair restoration practice.
At the conference, AesMed presented its latest advancements in:
CytoMesopecia – Cytokines Mesotherapy for Alopecia
A structured treatment framework developed to help medical professionals apply cytokine-based approaches in a more standardized and clinically meaningful way.
AGF39
A professional cytokine solution positioned for advanced mesotherapy applications in the hair-loss treatment field.
Advanced Scalp Care Solutions
AesMed’s evolving portfolio of scalp-focused products and treatment concepts designed to support the scalp microenvironment and complement professional hair restoration protocols.
The KSHRS meeting served as an important opportunity for AesMed to engage directly with hair transplant surgeons, physicians, and experts in hair restoration medicine, reinforcing its commitment to science-based innovation and clinically oriented product development.
Advancing Science-Driven Hair-Loss Solutions
AesMed’s participation in both KALDAT 2026 and KSHRS 2026 reflects the company’s ongoing mission to advance the field of hair-loss treatment through:
- Evidence-based clinical approaches
- Professional cytokine-based treatment frameworks
- Collaboration with dermatologists and hair restoration specialists
- Continuous development of scalp-care solutions for clinical practice
- Expansion of global academic and industry partnerships
By exhibiting at two of Korea’s significant dermatology and hair restoration meetings, AesMed reaffirmed its role as a company committed to bridging scientific innovation, clinical application, and global collaboration.
Looking Ahead
AesMed sincerely appreciates all medical professionals, partners, and visitors who stopped by its booths during KALDAT 2026 and KSHRS 2026.
The company will continue to share its clinical insights, strengthen partnerships with experts around the world, and develop innovative solutions that contribute to the future of hair-loss treatment, scalp health, and regenerative care.
“Some of the images were created using Miricanvas and Gemini.”
